5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-2,4-dioxo-1-beta-D-ribofur anosyl-, methyl ester structure
|
Common Name | 5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-2,4-dioxo-1-beta-D-ribofur anosyl-, methyl ester | ||
|---|---|---|---|---|
| CAS Number | 29428-50-0 | Molecular Weight | 316.26 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H16N2O8 | Melting Point | 160-162 °C | |
| MSDS | N/A | Flash Point | N/A | |
Use of 5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-2,4-dioxo-1-beta-D-ribofur anosyl-, methyl esterMethyl 1,2,3,4-tetrahydro-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidineacetate is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-methoxycarbonylmethyluridine |
|---|---|
| Synonym | More Synonyms |
| Description | Methyl 1,2,3,4-tetrahydro-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidineacetate is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 160-162 °C |
|---|---|
| Molecular Formula | C12H16N2O8 |
| Molecular Weight | 316.26 |
| Exact Mass | 316.09100 |
| PSA | 151.34000 |
| InChIKey | YIZYCHKPHCPKHZ-PNHWDRBUSA-N |
| SMILES | COC(=O)Cc1cn(C2OC(CO)C(O)C2O)c(=O)[nH]c1=O |
| Storage condition | -20°C |
| uridine 5-acetic acid methyl ester |
| 5-Methoxycarbonylmethyluridine |
| mcm(5)u |
| 5-Mcmu |
| methyl 2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]acetate |
| 5-(2-methoxy-2-oxoethyl)uridine |
| methyl uridine 5-acetate |